HDAC9 and cancer: Bioinformatic analysis of cancer patients using The Cancer Genome Atlas database has revealed that production of CD44v splice variants by an epigenetic mechanism, including HDAC inhibition, may sustain an epithelial phenotype and prevent epithelial-mesenchymal transition [24], thus corroborating this speculation.